Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Revenue (2016 - 2025)

Historic Revenue for Standard Biotools (LAB) over the last 17 years, with Q3 2025 value amounting to $19.6 million.

  • Standard Biotools' Revenue fell 1147.33% to $19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $190.3 million, marking a year-over-year increase of 6086.25%. This contributed to the annual value of $174.4 million for FY2024, which is 6403.23% up from last year.
  • Standard Biotools' Revenue amounted to $19.6 million in Q3 2025, which was down 1147.33% from $21.8 million recorded in Q2 2025.
  • Over the past 5 years, Standard Biotools' Revenue peaked at $108.2 million during Q4 2024, and registered a low of $18.8 million during Q2 2022.
  • Its 5-year average for Revenue is $32.4 million, with a median of $27.0 million in 2022.
  • Its Revenue has fluctuated over the past 5 years, first surged by 95787.1% in 2021, then crashed by 3946.42% in 2022.
  • Standard Biotools' Revenue (Quarter) stood at $38.3 million in 2021, then dropped by 29.38% to $27.0 million in 2022, then grew by 4.32% to $28.2 million in 2023, then surged by 283.85% to $108.2 million in 2024, then crashed by 81.93% to $19.6 million in 2025.
  • Its Revenue was $19.6 million in Q3 2025, compared to $21.8 million in Q2 2025 and $40.8 million in Q1 2025.